Follow
Hetty H. Helsmoortel
Hetty H. Helsmoortel
Postdoctoral cancer researcher, Ghent University
Verified email at ugent.be
Title
Cited by
Cited by
Year
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
J Van Deun, P Mestdagh, P Agostinis, Ö Akay, S Anand, J Anckaert, ...
Nature methods 14 (3), 228-232, 2017
9352017
Long noncoding RNA expression profiling in cancer: challenges and opportunities
L Lorenzi, F Avila Cobos, A Decock, C Everaert, H Helsmoortel, S Lefever, ...
Genes, Chromosomes and Cancer 58 (4), 191-199, 2019
1262019
Performance assessment of total RNA sequencing of human biofluids and extracellular vesicles
C Everaert, H Helsmoortel, A Decock, E Hulstaert, R Van Paemel, ...
Scientific reports 9 (1), 17574, 2019
592019
LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia
HH Helsmoortel, S Bresolin, T Lammens, H Cavé, P Noellke, A Caye, ...
Blood, The Journal of the American Society of Hematology 127 (9), 1163-1172, 2016
582016
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
A Beckers, G Van Peer, DR Carter, M Gartlgruber, C Herrmann, ...
Cancer letters 366 (1), 123-132, 2015
582015
Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia
F Ghazavi, B De Moerloose, W Van Loocke, A Wallaert, A Ferster, ...
Blood 128 (22), 3920, 2016
402016
Detecting long non-coding RNA biomarkers in prostate cancer liquid biopsies: Hype or hope?
H Helsmoortel, C Everaert, N Lumen, P Ost, J Vandesompele
Non-coding RNA Research 3 (2), 64-74, 2018
332018
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients
F Zeka, A Decock, A Van Goethem, K Vanderheyden, F Demuynck, ...
JCI insight 3 (23), 2018
292018
LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19
HH Helsmoortel, B De Moerloose, T Pieters, F Ghazavi, S Bresolin, ...
Haematologica 101 (6), e240, 2016
262016
Nolte-’t Hoen
J Van Deun, P Mestdagh, P Agostinis, Ö Akay, S Anand, J Anckaert, ...
O'Driscoll L, Palmulli R, Pfaffl MW, Primdal-Bengtson B, Romano E, Rousseau …, 2017
252017
’t Hoen, L
J Van Deun, P Mestdagh, P Agostinis, Ö Akay, S Anand, J Anckaert, ...
172017
The long non-coding RNA landscape in juvenile myelomonocytic leukemia
M Hofmans, T Lammens, HH Helsmoortel, S Bresolin, H Cavé, C Flotho, ...
Haematologica 103 (11), e501, 2018
132018
CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol
F Ghazavi, E Clappier, T Lammens, S Suciu, A Caye, S Zegrari, M Bakkus, ...
haematologica 100 (10), 1311, 2015
132015
Performance evaluation of RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control (exRNAQC) study
ExRNAQC Consortium, J Anckaert, F Avila Cobos, A Decock, ...
BioRxiv, 2021.05. 11.442610, 2021
72021
The extracellular RNA quality control (exRNAQC) study: testing and controlling pre-analytical variables of RNA sequencing on liquid biopsies
A Decock, O De Wever, B Dhondt, T D'huyvetter, H Helsmoortel, ...
LKI Symposium 2017: Liquid biopsies & cancer, 2017
22017
Substantial performance differences among RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control (exRNAQC) study
A Decock, O De Wever, C Everaert, H Helsmoortel, A Hendrix, ...
VIB Tools and Technologies Conference 2021: Revolutionizing Next-Generation …, 2021
12021
LIN28B defines an aggressive subtype of juvenile myelomonocytic leukemia
H Helsmoortel, T Lammens, F Ghazavi, A Caye, H Cavé, C Flotho, ...
19th Congress of the European Hematology Association 99 (suppl. 1), 235-236, 2014
12014
Subpar reporting of pre‐analytical variables in RNA‐focused blood plasma studies
C Van Der Schueren, P Decruyenaere, F Avila Cobos, J Bult, J Deleu, ...
Molecular Oncology, 2024
2024
Dramatic impact of blood collection tube and RNA purification method on extracellular RNA transcriptomes
J Anckaert, F Avila Cobos, A Decock, P Decruyenaere, J Deleu, ...
6th Advances in Circulating Tumor Cells, 2023
2023
Reporting of pre-analytical variables in RNA-focused blood plasma studies: a prerequisite for quality assessment and replication
C Van Der Schueren, P Decruyenaere, F Avila Cobos, J Bult, J Deleu, ...
6th Advances in Circulating Tumor Cells, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20